Theravance Biopharma (TBPH) Interest Coverage Ratio Growth (1y) (2017 - 2025)
Theravance Biopharma (TBPH) Interest Coverage Ratio Growth (1y) (2017 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
67.94% |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
340.32% |
| Sep 30, 2025 |
34.51% |
| Jun 30, 2025 |
83.15% |
| Mar 31, 2025 |
-25.99% |
| Dec 31, 2024 |
-42.85% |
| Sep 30, 2024 |
-19.59% |
| Jun 30, 2024 |
14.09% |
| Mar 31, 2024 |
60.66% |
| Dec 31, 2023 |
68.40% |
| Sep 30, 2023 |
-143.04% |
| Jun 30, 2023 |
-125.68% |
| Mar 31, 2023 |
-151.40% |
| Dec 31, 2022 |
39.90% |
| Sep 30, 2022 |
76.42% |
| Jun 30, 2022 |
-127.82% |
| Mar 31, 2022 |
-154.99% |
| Dec 31, 2021 |
-1,853.37% |
| Sep 30, 2021 |
-279.16% |
| Jun 30, 2021 |
12.87% |
| Mar 31, 2021 |
3.08% |
